02/14/2022
US FDA has issued guidance on use of non-human primates for use in General Toxicity and DART studies under current conditions of restricted availability.
The US Food and Drug Administration (FDA) is urging sponsors to find alternatives to nonhuman primates (NHPs) in their nonclinical toxicology studies and is especially discouraging their use for small molecule development programs. The announcement was prompted by the limited availability of monkeys...
